Pharma News

Join WhatsApp Channel 

Crack GPAT — Prepare for GPAT Online 

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Cognitive behavioral therapy enhances brain circuits to relieve depression
    9 September 2024

    Cognitive behavioral therapy enhances brain circuits to relieve depression

    A new study led by Stanford Medicine scientists found that certain changes in neural activity predicted which patients would benefit from a type of cognitive behavioral therapy.

    Cognitive behavioral therapy, one of the most common treatments for depression, can teach skills for coping with everyday troubles, reinforce healthy behaviors and counter negative thoughts. But can altering thoughts and behaviors lead to lasting changes in the brain?

  • 6 September 2024
    GSK announces positive results from phase III trial of Nucala (mepolizumab) in COPD
    GSK plc announced positive headline results of MATINEE, the phase III clinical trial evaluating Nucala mepolizumab, a monoclonal antibody that targets interleukin-5 in adults with chronic obstructive pulmonary disease.
  • 6 September 2024
    Alembic Pharmaceuticals announces USFDA Final Approval for Albendazole Tablets USP, 200 mg

    Alembic Pharmaceuticals Limited, a vertically integrated research and development pharmaceutical company, has been at the forefront of healthcare since 1907. Headquartered in India, Alembic is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world. Alembic's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA. Alembic is one of the leaders in branded generics in India.

  • 6 September 2024
    Strides receive USFDA approval for Theophylline Extended-Release Tablets, 300 mg and 450 mg
    Strides Pharma Science Limited announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for the generic version of Theophylline Extended-Release Tablets, 300 mg and 450 mg, from the United States Food & Drug Administration
  • 6 September 2024
    Sun Pharma and Moebius Medical Announce Fast Track Designation Granted for MM-II for the Treatment of Osteoarthritis Knee Pain
    Sun Pharma and Israel-based Moebius Medical Limited announced that the U.S. Food and Drug Administration has granted Fast Track designation to MM-II Large Liposomes of DPPC and DMPC for the treatment of osteoarthritis knee pain. Planning for confirmatory Phase 3 clinical trials for MM- II is underway.
  • 3 September 2024
    Dr. Akram Ahmad, Founder of Academically Global, Honored with BW Healthcare World 40 Under 40 Award 2024

    Dr. Akram Ahmad, founder of Academically Global, has been recognized as one of the recipients of the prestigious BW HealthcareWorld 40 Under 40 Awards 2024. The awards ceremony took place on August 31, 2024, at The Imperial Hotel, Janpath, New Delhi. This accolade celebrates the dynamic young leaders shaping the future of healthcare in India.

  • 2 September 2024
    Mechanisms of how morphine relieves pain mapped out

    In a study published in Science, researchers at Karolinska Institutet describe the neural processes behind how morphine relieves pain. This is valuable knowledge because the drug has such serious side effects. 

    Morphine is a powerful painkiller that belongs to the group of opioids. It blocks signals in the pain pathways and also increases feelings of pleasure.  Morphine acts on several central and peripheral pain pathways in the body, but the neural processes behind the pain relief have not previously been fully understood.  

  • 2 September 2024
    New findings on TB could change how we treat inflammatory disorders
    Tuberculosis is a confounding scourge. Its the leading cause of death from infectious disease in the world, and yet its estimated that those deaths represent perhaps 5% of infections with Mycobacterium tuberculosis.
  • 29 August 2024
    Now Graduation mandatory for recruitment as CGHS Pharmacist
    ​The Central Government has released new rules for the recruitment of pharmacists in the Central Government Health Scheme, CGHS. According to the new recruitment rules published in the Government of India Gazette Notification, the minimum educational qualification for recruitment to the post of pharmacist in CGHS has been set to a graduation degree.
  • 28 August 2024
    Gut Bacteria Composition Influences Rotavirus Vaccine Efficacy

    Certain types of gut bacteria can hinder the efficacy of the rotavirus vaccine, according to researchers in the Institute for Biomedical Sciences at Georgia State University.

Subscribe to Pharma News